Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Psychemedics Corp. ?
1
Poor Management Efficiency with a low ROE of 0.53%
- The company has been able to generate a Return on Equity (avg) of 0.53% signifying low profitability per unit of shareholders funds
2
Positive results in Dec 24
- DEBTORS TURNOVER RATIO(HY) Highest at 6.32 times
- OPERATING PROFIT(Q) Highest at USD 0.58 MM
- OPERATING PROFIT MARGIN(Q) Highest at 13.13 %
3
Risky - Negative Operating Profits
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -15.38%, its profits have risen by 49%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -15.38% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Psychemedics Corp. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Psychemedics Corp. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Psychemedics Corp.
-18.41%
-0.38
33.36%
S&P 500
13.22%
0.61
20.17%
Quality key factors
Factor
Value
Sales Growth (5y)
-12.17%
EBIT Growth (5y)
-191.17%
EBIT to Interest (avg)
-2.35
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
2.60
Tax Ratio
2.87%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.37%
ROCE (avg)
0.33%
ROE (avg)
0.53%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.93
EV to EBIT
-7.55
EV to EBITDA
14.29
EV to Capital Employed
3.25
EV to Sales
0.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-43.00%
ROE (Latest)
-36.24%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Psychemedics Corp.
Pre-Tax Profit
At USD 0.16 MM has Grown at 121.75%
over average net sales of the previous four periods of USD -0.74 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.19 MM has Grown at 125.32%
over average net sales of the previous four periods of USD -0.75 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Profit
Highest at USD 0.58 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 13.13 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 0.16 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 0.19 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.03
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 6.32 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Psychemedics Corp.
Net Sales
At USD 4.42 MM has Fallen at -12.63%
over average net sales of the previous four periods of USD 5.06 MMMOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Net Sales
Lowest at USD 4.42 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Cash and Eqv
Lowest at USD 2.82 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 24.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






